SCHEMBL2490409

SCHEMBL2490409

COc1ccc(COCCO)c(-c2ccccc2)c1-c1ccccc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CD274 Q9NZQ7 2/20 0.38
FABP3 P05413 2/20 0.38
FABP5 Q01469 2/20 0.38
FABP4 P15090 1/20 0.38
ALDH1A1 P00352 3/20 0.36
DHPS P49366 1/20 0.36
TUBB1 Q9H4B7 1/20 0.36
RECQL P46063 1/20 0.36
PDE4B Q07343 5/20 0.36
PDE4A P27815 4/20 0.36
PDE4C Q08493 4/20 0.36
PDE4D Q08499 4/20 0.36
MGAM O43451 1/20 0.35
GAA P10253 1/20 0.35
SI P14410 1/20 0.35
MGAM2 Q2M2H8 1/20 0.35
TDO2 P48775 1/20 0.35
KDM4E B2RXH2 1/20 0.34
HPGD P15428 1/20 0.34
HSD17B10 Q99714 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2490820 0.85 TAAR1 (0.39) CD274
SCHEMBL2490787 0.81 KDM4E (0.45) CD274FABP3FABP5FABP4ALDH1A1
SCHEMBL2494551 0.78 PDE4B (0.42) CD274ALDH1A1RECQLPDE4BPDE4A
SCHEMBL694510 0.76 IDO1 (0.56) ALDH1A1GAAHPGD
SCHEMBL2492139 0.75 CD274 (0.50) CD274ALDH1A1KDM4E
SCHEMBL2491619 0.75 CD274 (0.39) CD274ALDH1A1RECQL
SCHEMBL8871797 0.75 ALDH1A1 (0.37) ALDH1A1RECQLKDM4EHPGD
SCHEMBL9706208 0.74 FABP3 (0.40) FABP3FABP5FABP4ALDH1A1PDE4B
SCHEMBL9845248 0.74 AR (0.39) FABP3FABP5FABP4ALDH1A1PDE4B
SCHEMBL2491936 0.73 ALDH1A1 (0.38) ALDH1A1RECQLPDE4BPDE4APDE4C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2380567-B1 MELANIN PRODUCTION INHIBITOR POLA CHEM IND INC (JP) 2019-01-16 EP disclosed
EP-3009123-A1 MELANIN PRODUCTION INHIBITOR Pola Chemical Industries Inc. (JP) 2016-04-20 EP disclosed
US-20150328107-A1 MELANIN PRODUCTION INHIBITOR POLA CHEMICAL INDUSTRIES INC. (JP) 2015-11-19 US disclosed
EP-2845587-A2 Melanin production inhibitor Pola Chemical Industries Inc. (JP) 2015-03-11 EP disclosed
US-20140363389-A1 MELANIN PRODUCTION INHIBITOR POLA CHEMICAL INDUSTRIES INC. (JP) 2014-12-11 US disclosed
US-8846012-B2 Melanin production inhibitor POLA CHEMICAL INDUSTRIES INC. (JP) 2014-09-30 US disclosed
EP-2380567-A1 MELANIN PRODUCTION INHIBITOR Pola Chemical Industries Inc. (JP) 2011-10-26 EP disclosed
US-20110243865-A1 MELANIN PRODUCTION INHIBITOR POLA CHEMICAL INDUSTRIES INC. (JP) 2011-10-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110243865-A1 MELANIN PRODUCTION INHIBITOR TYR, F12, TH CD274 3091/4885FABP3 4861/4885FABP5 4860/4885
US-20150328107-A1 MELANIN PRODUCTION INHIBITOR TYR, MC1R, F12 CD274 2885/4885FABP3 4847/4885FABP5 4850/4885
US-20140363389-A1 MELANIN PRODUCTION INHIBITOR TYR, F12, MC1R CD274 2825/4885FABP3 4859/4885FABP5 4853/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.